Perrigo Company plc (PIG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Perrigo Company plc (PIG) has a cash flow conversion efficiency ratio of 0.012x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€51.70 Million ≈ $60.44 Million USD) by net assets (€4.45 Billion ≈ $5.20 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Perrigo Company plc - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Perrigo Company plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PIG total liabilities for a breakdown of total debt and financial obligations.
Perrigo Company plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Perrigo Company plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bukit Uluwatu Villa Tbk
JK:BUVA
|
0.023x |
|
Harrow Health Inc
NASDAQ:HROW
|
0.356x |
|
Guangdong Homa Appliances Co Ltd
SHE:002668
|
0.117x |
|
Hyundai Green Food Co Ltd
KO:005440
|
0.008x |
|
Thai Union Group Public Company Limited
BK:TU-R
|
0.056x |
|
Jiangxi Ganyue Expressway Co Ltd
SHG:600269
|
0.028x |
|
Maharashtra Scooters Limited
NSE:MAHSCOOTER
|
0.007x |
|
Telecom Argentina S.A
F:TEO
|
0.093x |
Annual Cash Flow Conversion Efficiency for Perrigo Company plc (2016–2024)
The table below shows the annual cash flow conversion efficiency of Perrigo Company plc from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see Perrigo Company plc (PIG) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €4.32 Billion ≈ $5.05 Billion |
€362.90 Million ≈ $424.27 Million |
0.084x | -1.21% |
| 2023-12-31 | €4.77 Billion ≈ $5.57 Billion |
€405.50 Million ≈ $474.07 Million |
0.085x | +34.01% |
| 2022-12-31 | €4.84 Billion ≈ $5.66 Billion |
€307.30 Million ≈ $359.27 Million |
0.063x | +109.18% |
| 2021-12-31 | €5.15 Billion ≈ $6.02 Billion |
€156.30 Million ≈ $182.73 Million |
0.030x | -73.03% |
| 2020-12-31 | €5.66 Billion ≈ $6.61 Billion |
€636.20 Million ≈ $743.78 Million |
0.113x | +68.38% |
| 2019-12-31 | €5.80 Billion ≈ $6.79 Billion |
€387.80 Million ≈ $453.38 Million |
0.067x | -36.14% |
| 2018-12-31 | €5.67 Billion ≈ $6.63 Billion |
€593.00 Million ≈ $693.28 Million |
0.105x | -7.63% |
| 2017-12-31 | €6.17 Billion ≈ $7.21 Billion |
€698.90 Million ≈ $817.09 Million |
0.113x | +3.03% |
| 2016-12-31 | €5.96 Billion ≈ $6.97 Billion |
€654.90 Million ≈ $765.65 Million |
0.110x | -- |
About Perrigo Company plc
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nut… Read more